Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review.
Nicolatou-Galitis O, Kouri M, Papadopoulou E, Vardas E, Galiti D, Epstein JB, Elad S, Campisi G, Tsoukalas N, Bektas-Kayhan K, Tan W, Body JJ, Migliorati C, Lalla RV; MASCC Bone Study Group.
Support Care Cancer. 2019 Feb;27(2):383-394. doi: 10.1007/s00520-018-4501-x. Epub 2018 Oct 23.
PMID:30353228
Relationship between tooth extraction and development of medication-related osteonecrosis of the jaw in cancer patients.
Soutome S, Otsuru M, Hayashida S, Murata M, Yanamoto S, Sawada S, Kojima Y, Funahara M, Iwai H, Umeda M, Saito T.
Sci Rep. 2021 Aug 26;11(1):17226. doi: 10.1038/s41598-021-96480-8.
PMID:34446755
Teriparatide Promotes Bone Healing in Medication-Related Osteonecrosis of the Jaw: A Placebo-Controlled, Randomized Trial.
N Engl J Med. 2023 May 25;388(21):e69. doi: 10.1056/NEJMicm2209172. Epub 2023 May 20.
PMID:37212416
Systematic review of medication related osteonecrosis of the jaw (MRONJ) in patients undergoing only antiangiogenic drug therapy: surgery or conservative therapy?
Sacco R, Woolley J, Patel G, Calasans-Maia MD, Yates J.